An official website of the United States government
Home
Name
Eligard
Alternate Names
Lupron
Leuprolide Acetate
Abbreviations
None
Category
Hormones and hormonal mechanisms
Subcategory
LHRH
NSC Number
None
Primary Site
Prostate cancer
Breast
Histology
None
Remarks
December 2016 Update: Lupron as ovarian suppressor in pre-menopausal breast cancer has been approved by the FDA per NCI. Beginning with cases diagnosed 1/1/2017 forward, code as hormone therapy.
Lupron is a gonadotropin-releasing hormone analogue. FDA approved its use on prostate cancer and should be coded as hormone therapy.
FOR BREAST CASES DIAGNOSED 1/1/2017 FORWARD: Code as hormone treatment
Lupron is a gonadotropin-releasing hormone analogue. FDA approved its use on prostate cancer and should be coded as hormone therapy.
FOR BREAST CASES DIAGNOSED 1/1/2017 FORWARD: Code as hormone treatment
Coding
This drug should be coded
